Challenges in Routine Clinical Chemistry Testing. Analysis of Small Molecules.

Accurate Results in the Clinical Laboratory: A Guide to Error Detection and Correction

Volumn , Issue , 2013, Pages 93-129

  Sepulveda, Jorge ^a  

^a Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902071038     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-415783-5.00008-6     Document Type: Chapter

References (109)

1. Young D.S. Effects of drugs on clinical laboratory tests 2000, AACC Press, Washington, DC. 3rd ed.
2. Young D.S. Effects of preanalytical variables on clinical laboratory tests 2007, AACC Press, Washington, DC. 3rd ed.
3. Guder W.G., Narayanan S., Wisser H., Zawta B. Diagnostic samples: from the patient to the laboratory. The impact of preanalytical variables on the quality of laboratory results 2009, Wiley-Blackwell, Weinheim, Germany. 4th ed.
4. Wyss M., Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev 2000, 80(3):1107-1213.
5. Levey A.S., Coresh J., Greene T., Marsh J., Stevens L.A., Kusek J.W., et al. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007, 53(4):766-772.
6. Schwartz G.J., Munoz A., Schneider M.F., Mak R.H., Kaskel F., Warady B.A., et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009, 20(3):629-637.
7. Andreev E., Koopman M., Arisz L. A rise in plasma creatinine that is not a sign of renal failure: which drugs can be responsible?. J Intern Med 1999, 246(3):247-252.
8. Maillard N., Mehdi M., Thibaudin L., Berthoux F., Alamartine E., Mariat C. Creatinine-based GFR predicting equations in renal transplantation: reassessing the tubular secretion effect. Nephrol Dial Transplant 2010, 25(9):3076-3082.
9. Stevens L.A., Nolin T.D., Richardson M.M., Feldman H.I., Lewis J.B., Rodby R., et al. Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis 2009, 54(1):33-42.
10. Peake M., Whiting M. Measurement of serum creatinine-Current status and future goals. Clin Biochem Rev 2006, 27(4):173-184.
11. Molitch M.E., Rodman E., Hirsch C.A., Dubinsky E. Spurious serum creatinine elevations in ketoacidosis. Ann Intern Med 1980, 93(2):280-281.
12. Mascioli S.R., Bantle J.P., Freier E.F., Hoogwerf B.J. Artifactual elevation of serum creatinine level due to fasting. Arch Intern Med 1984, 144(8):1575-1576.
13. Kemperman F.A., Weber J.A., Gorgels J., van Zanten A.P., Krediet R.T., Arisz L. The influence of ketoacids on plasma creatinine assays in diabetic ketoacidosis. J Intern Med 2000, 248(6):511-517.
14. Sheikh-Ali M., Karon B.S., Basu A., Kudva Y.C., Muller L.A., Xu J., et al. Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis?. Diabetes Care 2008, 31(4):643-647.
15. Chadha V., Garg U., Warady B.A., Alon U.S. Sieving coefficient inaccuracies during hemodiafiltration in patients with hyperbilirubinemia. Pediatr Nephrol 2000, 15(1-2):33-35.
16. Andersson A.-C., Strandberg K., Becker C., Hägglöf-Persson A., Lundström G., Thämlitz R., et al. Interference testing of the creatinine sensor in the ABL837 FLEX analyzer. Point of Care 2007, 6(2):139-143.
17. Saenger A.K., Lockwood C., Snozek C.L., Milz T.C., Karon B.S., Scott M.G., et al. Catecholamine interference in enzymatic creatinine assays. Clin Chem 2009, 55(9):1732-1736.
18. Karon B.S., Daly T.M., Scott M.G. Mechanisms of dopamine and dobutamine interference in biochemical tests that use peroxide and peroxidase to generate chromophore. Clin Chem 1998, 44(1):155-160.
19. Rachoin J.S., Daher R., Moussallem C., Milcarek B., Hunter K., Schorr C., et al. The fallacy of the BUN:creatinine ratio in critically ill patients. Nephrol Dial Transplant 2011, 27:2248-2255.
20. Beier K., Eppanapally S., Bazick H.S., Chang D., Mahadevappa K., Gibbons F.K., et al. Elevation of blood urea nitrogen is predictive of long-term mortality in critically ill patients independent of "normal" creatinine. Crit Care Med 2011, 39(2):305-313.
21. Miyaji H., Ito S., Azuma T., Ito Y., Yamazaki Y., Ohtaki Y., et al. Effects of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis. Gut 1997, 40(6):726-730.
22. Dufour D.R., Lott J.A., Nolte F.S., Gretch D.R., Koff R.S., Seeff L.B. Diagnosis and monitoring of hepatic injury: I. Performance characteristics of laboratory tests. Clin Chem 2000, 46(12):2027-2049.
23. Degoutte F., Jouanel P., Begue R.J., Colombier M., Lac G., Pequignot J.M., et al. Food restriction, performance, biochemical, psychological, and endocrine changes in judo athletes. Int J Sports Med 2006, 27(1):9-18.
24. Urea Cycle Disorders Conference Group Consensus statement from a conference for the management of patients with urea cycle disorders. J Pediatr 2001, 138(1 Suppl):S1-S5.
25. da Fonseca-Wollheim F. Preanalytical increase of ammonia in blood specimens from healthy subjects. Clin Chem 1990, 36(8 Pt 1):1483-1487.
26. da Fonseca-Wollheim F. Deamidation of glutamine by increased plasma gamma-glutamyltransferase is a source of rapid ammonia formation in blood and plasma specimens. Clin Chem 1990, 36(8 Pt 1):1479-1482.
27. Herrera D.J., Moore S., Heap S., Preece M.A., Griffiths P. Can plasma ammonia be measured in patients with acute liver disease?. Ann Clin Biochem 2008, 45(4):426-428.
28. Herrera D.J., Hutchin T., Fullerton D., Gray G. Non-specific interference in the measurement of plasma ammonia: importance of using a sample blank. Ann Clin Biochem 2010, 47(Pt 1):81-83.
29. da Fonseca-Wollheim F., Heinze K.G. Which is the appropriate coenzyme for the measurement of ammonia with glutamate dehydrogenase?. Eur J Clin Chem Clin Biochem 1992, 30(9):537-540.
30. Lloyd-Mostyn R.H., Lord P.S., Glover R., West C., Gilliland I.C. Uric acid metabolism in starvation. Ann Rheum Dis 1970, 29(5):553-555.
31. Yamamoto T., Moriwaki Y., Takahashi S. Effect of ethanol on metabolism of purine bases (hypoxanthine, xanthine, and uric acid). Clin Chim Acta 2005, 356(1-2):35-57.
32. Wood W.G. The determination of uric acid in urine-Forgotten problems rediscovered in an external quality assessment scheme. Clin Lab 2009, 55(9-10):341-352.
33. Hande K.R., Perini F., Putterman G., Elin R. Hyperxanthinemia interferes with serum uric acid determinations by the uricase method. Clin Chem 1979, 25(8):1492-1494.
34. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(Suppl. 1):S62-S69.
35. Sacks D.B., Arnold M., Bakris G.L., Bruns D.E., Horvath A.R., Kirkman M.S., et al. Executive summary: guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2011, 57(6):793-798.
36. Metzger B.E., Gabbe S.G., Persson B., Buchanan T.A., Catalano P.A., Damm P., et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010, 33(3):676-682.
37. Burtis C.A., Ashwood E.R., Bruns D.E. Tietz textbook of clinical chemistry and molecular diagnostics 2012, Elsevier, St. Louis, MO. 5th ed.
38. Watson K.R., O'Kell R.T., Joyce J.T. Data regarding blood drawing sites in patients receiving intravenous fluids. Am J Clin Pathol 1983, 79(1):119-121.
39. D'Orazio P., Burnett R.W., Fogh-Andersen N., Jacobs E., Kuwa K., Kulpmann W.R., et al. Approved IFCC recommendation on reporting results for blood glucose: international federation of clinical chemistry and laboratory medicine scientific division, working group on selective electrodes and point-of-care testing (IFCC-SD-WG-SEPOCT). Clin Chem Lab Med 2006, 44(12):1486-1490.
40. Tang Z., Du X., Louie R.F., Kost G.J. Effects of drugs on glucose measurements with handheld glucose meters and a portable glucose analyzer. Am J Clin Pathol 2000, 113(1):75-86.
41. Gaines AR, Pierce LR, Bernhardt PA. Fatal Iatrogenic Hypoglycemia: Falsely Elevated Blood Glucose Readings with a Point-of-Care Meter Due to a Maltose-Containing Intravenous Immune Globulin Product. 2009 06/18/2009 [cited; Available from: <>. http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ucm155099.htm.
42. Food and Drug Administration. FDA Public Health Notification: Potentially Fatal Errors with GDH-PQQ* Glucose Monitoring Technology. 2009 03/09/2012 [cited; Available from: <>. http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/ucm176992.htm.
43. Schleis T.G. Interference of maltose, icodextrin, galactose, or xylose with some blood glucose monitoring systems. Pharmacotherapy 2007, 27(9):1313-1321.
44. Schrier R. Renal and electrolyte disorders 2010, Lippincott, Philadelphia.
45. Smellie W.S. Spurious hyperkalaemia. BMJ 2007, 334(7595):693-695.
46. Kroll M.H., Elin R.J. Relationships between magnesium and protein concentrations in serum. Clin Chem 1985, 31(2):244-246.
47. Dickerson R.N., Alexander K.H., Minard G., Croce M.A., Brown R.O. Accuracy of methods to estimate ionized and "corrected" serum calcium concentrations in critically ill multiple trauma patients receiving specialized nutrition support. J Parenter Enteral Nutr 2004, 28(3):133-141.
48. Ferrari P., Singer R., Agarwal A., Hurn A., Townsend M.A., Chubb P. Serum phosphate is an important determinant of corrected serum calcium in end-stage kidney disease. Nephrology 2009, 14(4):383-388.
49. Tong G.M., Rude R.K. Magnesium deficiency in critical illness. J Intensive Care Med 2005, 20(1):3-17.
50. Solomon R., Weinberg M.S., Dubey A. The diurnal rhythm of plasma potassium: relationship to diuretic therapy. J Cardiovasc Pharmacol 1991, 17(5):854-859.
51. Clausen T. Hormonal and pharmacological modification of plasma potassium homeostasis. Fundam Clin Pharmacol 2010, 24(5):595-605.
52. Ljunghall S., Joborn H., Rastad J., Akerstrom G. Plasma potassium and phosphate concentrations-Influence by adrenaline infusion, beta-blockade and physical exercise. Acta Med Scand 1987, 221(1):83-93.
53. Adrogue H.J., Madias N.E. Changes in plasma potassium concentration during acute acid-base disturbances. Am J Med 1981, 71(3):456-467.
54. Cardinal P., Allan J., Pham B., Hindmarsh T., Jones G., Delisle S. The effect of sodium citrate in arterial catheters on acid-base and electrolyte measurements. Crit Care Med 2000, 28(5):1388-1392.
55. Dimeski G., Badrick T., John A.S. Ion selective electrodes (ISEs) and interferences-A review. Clin Chim Acta 2010, 411(5-6):309-317.
56. Wulkan R.W., Michiels J.J. Pseudohyperkalaemia in thrombocythaemia. J Clin Chem Clin Biochem 1990, 28(7):489-491.
57. Hira K., Shimbo T., Fukui T. High serum potassium concentrations after recentrifugation of stored blood specimens. N Engl J Med 2000, 343(2):153-154.
58. Mansour M.M.H., Azzazy H.M.E., Kazmierczak S.C. Correction factors for estimating potassium concentrations in samples with in vitro hemolysis: a detriment to patient safety. Arch Pathol Lab Med 2009, 133(6):960-966.
59. Hawkins R.C. EDTA contamination of serum samples: common but not necessarily significant. Ann Clin Biochem 2011, 48(Pt 5):478.
60. Davidson D.F. EDTA analysis on the roche MODULAR analyser. Ann Clin Biochem 2007, 44(Pt 3):294-296.
61. Kirschbaum B. Loss of carbon dioxide from serum samples exposed to air: effect on blood gas parameters and strong ions. Clin Chim Acta 2003, 334(1-2):241-244.
62. Herr R.D., Swanson T. Pseudometabolic acidosis caused by underfill of Vacutainer tubes. Ann Emerg Med 1992, 21(2):177-180.
63. Waugh W.H. Utility of expressing serum sodium per unit of water in assessing hyponatremia. Metabolism 1969, 18(8):706-712.
64. Nguyen M.K., Ornekian V., Butch A.W., Kurtz I. A new method for determining plasma water content: application in pseudohyponatremia. Am J Physiol Renal Physiol 2007, 292(5):F1652-F1656.
65. Sivakumar T., Chaidarun S., Lee H.K., Cervinski M., Comi R. Multiple lipoprotein and electrolyte laboratory artifacts caused by lipoprotein X in obstructive biliary cholestasis secondary to pancreatic cancer. J Clin Lipidol 2011, 5(4):324-328.
66. Turchin A., Seifter J.L., Seely E.W. Mind the gap. N Engl J Med 2003, 349(15):1465-1469.
67. Al-Musheifri A., Jones G.R. Glucose interference in direct ion-sensitive electrode sodium measurements. Ann Clin Biochem 2008, 45(Pt 5):530-532.
68. Meng Q.H., Irwin W.C., Fesser J., Massey K.L. Interference of ascorbic acid with chemical analytes. Ann Clin Biochem 2005, 42(Pt 6):475-477.
69. Goldwasser P., Manjappa N.G., Luhrs C.A., Barth R.H. Pseudohypobicarbonatemia caused by an endogenous assay interferent: a new entity. Am J Kidney Dis 2011, 58(4):617-620.
70. Lovekar S., Chen J.L. A 90-year-old man with hyperphosphatemia. Am J Kidney Dis 2011, 57(2):342-346.
71. Dalal B.I., Brigden M.L. Factitious biochemical measurements resulting from hematologic conditions. Am J Clin Pathol 2009, 131(2):195-204.
72. Loh T.P., Saw S., Sethi S.K. Hyperphosphatemia in a 56-year-old man with hypochondrial pain. Clin Chem 2010, 56(6):892-895.
73. Toftegaard M., Rees S.E., Andreassen S. Evaluation of a method for converting venous values of acid-base and oxygenation status to arterial values. Emerg Med J. 2009, 26(4):268-272.
74. Herrington W.G., Nye H.J., Hammersley M.S., Watkinson P.J. Are arterial and venous samples clinically equivalent for the estimation of pH, serum bicarbonate and potassium concentration in critically ill patients?. Diabet Med 2012, 29(1):32-35.
75. Yildizdas D., Yapicioglu H., Yilmaz H.L., Sertdemir Y. Correlation of simultaneously obtained capillary, venous, and arterial blood gases of patients in a paediatric intensive care unit. Arch Dis Child 2004, 89(2):176-180.
76. 2 to screen for arterial hypercarbia in patients with chronic obstructive airways disease. J Emerg Med 2005, 28(4):377-379.
77. 2 by collection of arterial blood gas values with the butterfly infusion set. J Perinatol 1993, 13(1):65-67.
78. Lu J.Y., Kao J.T., Chien T.I., Lee T.F., Tsai K.S. Effects of air bubbles and tube transportation on blood oxygen tension in arterial blood gas analysis. J Formos Med Assoc 2003, 102(4):246-249.
79. Collinson P.O., John C.M., Gaze D.C., Ferrigan L.F., Cramp D.G. Changes in blood gas samples produced by a pneumatic tube system. J Clin Pathol 2002, 55(2):105-107.
80. 2, and pH in fresh blood samples stored in a plastic syringe with low heparin in relation to various blood-gas and hematological parameters. Clin Biochem 1999, 32(2):101-107.
81. Knowles T.P., Mullin R.A., Hunter J.A., Douce F.H. Effects of syringe material, sample storage time, and temperature on blood gases and oxygen saturation in arterialized human blood samples. Respir Care 2006, 51(7):732-736.
82. Cengiz M., Ulker P., Meiselman H.J., Baskurt O.K. Influence of tourniquet application on venous blood sampling for serum chemistry, hematological parameters, leukocyte activation and erythrocyte mechanical properties. Clin Chem Lab Med 2009, 47(6):769-776.
83. Gourlain H., Buneaux F., Borron S.W., Gouget B., Levillain P. Interference of methylene blue with CO-oximetry of hemoglobin derivatives. Clin Chem 1997, 43(6 Pt 1):1078-1080.
84. Smith I., Kumar P., Molloy S., Rhodes A., Newman P.J., Grounds R.M., et al. Base excess and lactate as prognostic indicators for patients admitted to intensive care. Intensive Care Med 2001, 27(1):74-83.
85. Mikami A., Ohde S., Deshpande G., Mochizuki T., Otani N., Ishimatsu S. Can we predict arterial lactate from venous lactate in the emergency department?. Critical Care 2012, 16(Suppl 1):P259.
86. Jones A.E., Leonard M.M., Hernandez-Nino J., Kline J.A. Determination of the effect of in vitro time, temperature, and tourniquet use on whole blood venous point-of-care lactate concentrations. Acad Emerg Med 2007, 14(7):587-591.
87. Astles R., Williams C.P., Sedor F. Stability of plasma lactate in vitro in the presence of antiglycolytic agents. Clin Chem 1994, 40(7 Pt 1):1327-1330.
88. Brindley P.G., Butler M.S., Cembrowski G., Brindley D.N. Falsely elevated point-of-care lactate measurement after ingestion of ethylene glycol. CMAJ 2007, 176(8):1097-1099.
89. National Institutes of Health. Household Products Database: Ethylene Glycol. 2011 October, 2011 [cited 2012; Available from: <>. http://www.hpd.nlm.nih.gov/cgi-bin/household/search?queryx=107-21-1&tbl=TblChemicals&prodcat=all.
90. Porter W.H., Crellin M., Rutter P.W., Oeltgen P. Interference by glycolic acid in the Beckman synchron method for lactate: a useful clue for unsuspected ethylene glycol intoxication. Clin Chem 2000, 46(6 Pt 1):874-875.
91. Chiu W.W. Glycolate interference on radiometer ABL analyser is influenced by age of lactate electrode. CMAJ 2007, 176:1097-1099.
92. Jorens P.G. Accuracy of point-of-care measurements. CMAJ. 2007, 177(9):1070.
93. Ostrea E.M., Ongtengco E.A., Tolia V.A., Apostol E. The occurrence and significance of the bilirubin species, including delta bilirubin, in jaundiced infants. J Pediatr Gastroenterol Nutr 1988, 7(4):511-516.
94. Lo S.F., Doumas B.T. The status of bilirubin measurements in U.S. laboratories: why is accuracy elusive?. Semin Perinatol 2011, 35(3):141-147.
95. Al Riyami N., Zimmerman A.C., Rosenberg F.M., Holmes D.T. Spurious hyperbilirubinemia caused by naproxen. Clin Biochem 2009, 42(1-2):129-131.
96. Dasgupta A., Langman L.J., Johnson M., Chow L. Naproxen metabolites interfere with certain bilirubin assays. Am J Clin Pathol 2010, 133(6):878-883.
97. Ahlfors C.E., Wennberg R.P., Ostrow J.D., Tiribelli C. Unbound (free) bilirubin: Improving the paradigm for evaluating neonatal jaundice. Clin Chem 2009, 55(7):1288-1299.
98. Mora S., Rifai N., Buring J.E., Ridker P.M. Comparison of LDL cholesterol concentrations by Friedewald calculation and direct measurement in relation to cardiovascular events in 27,331 women. Clin Chem 2009, 55(5):888-894.
99. Grundy S.M., Cleeman J.I., Merz C.N., Brewer H.B., Clark L.T., Hunninghake D.B., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004, 110(2):227-239.
100. Ridker P.M. Fasting versus nonfasting triglycerides and the prediction of cardiovascular risk: do we need to revisit the oral triglyceride tolerance test?. Clin Chem 2008, 54(1):11-13.
101. Fresco C., Maggioni A.P., Signorini S., Merlini P.A., Mocarelli P., Fabbri G., et al. Variations in lipoprotein levels after myocardial infarction and unstable angina: the LATIN trial. Ital Heart J. 2002, 3(10):587-592.
102. Pitt B., Loscalzo J., Ycas J., Raichlen J.S. Lipid levels after acute coronary syndromes. J Am Coll Cardiol 2008, 51(15):1440-1445.
103. Henkin Y., Crystal E., Goldberg Y., Friger M., Lorber J., Zuili I., et al. Usefulness of lipoprotein changes during acute coronary syndromes for predicting postdischarge lipoprotein levels. Am J Cardiol 2002, 89(1):7-11.
104. Gylling H., Hallikainen M., Nissinen M.J., Simonen P., Miettinen T.A. Very high plant stanol intake and serum plant stanols and non-cholesterol sterols. Eur J Nutr 2010, 49(2):111-117.
105. Perera N.J., Burns J.C., Perera R.S., Lewis B., Sullivan D.R. Adjustment of direct high-density lipoprotein cholesterol measurements according to intercurrent triglyceride corrects for interference by triglyceride-rich lipoproteins. J Clin Lipidol 2010, 4(4):305-309.
106. Miller W.G., Myers G.L., Sakurabayashi I., Bachmann L.M., Caudill S.P., Dziekonski A., et al. Seven direct methods for measuring HDL and LDL cholesterol compared with ultracentrifugation reference measurement procedures. Clin Chem 2010, 56(6):977-986.
107. Murali M.R., Kratz A., Finberg K.E. Case records of the Massachusetts General Hospital. Case 40-2006: a 64-year-old man with anemia and a low level of HDL cholesterol. N Engl J Med 2006, 355(26):2772-2779.
108. Walmsley T.A., Potter H.C., George P.M., Florkowski C.M. Pseudo-hypertriglyceridaemia: a measurement artefact due to glycerol kinase deficiency. Postgrad Med J. 2008, 84(996):552-554.
109. Cascavilla N., Falcone A., Sanpaolo G., D'Arena G. Increased serum bilirubin level without jaundice in patients with monoclonal gammopathy. Leuk Lymphoma 2009, 50(8):1392-1394.